In this Wednesday, Nov. 18, 2020 file photo, lobsters sit in a crate at a shipping facility in Arundel, Maine. The European Union parliament on Thursday, Nov. 26, 2020 approved a mini trade deal with the United States, which includes the elimination of customs duties on U.S. lobster imports. The passage by a vote of with 638 votes for, 45 against and 11 abstentions was the last major political step for the deal to come into effect. (AP Photo/Robert F. Bukaty, FIle)
BRUSSELS (AP) — Thanksgiving just got a little bit better for the Maine lobster industry.
The European Union parliament on Thursday approved a mini trade deal with the United States, which includes the elimination of customs duties on U.S. lobster imports. The passage with 638 votes for, 45 against and 11 abstentions was the last major political step for the deal to come into effect.
As a result, the 27-nation EU will drop its 8% tariff on U.S. lobsters for the next five years and work to make the move permanent.
U.S. lobster imports to the EU came to about $111 million in 2017 before falling off in the face of rising tensions between the trading partners, and an EU trade agreement with Canada that allowed its lobsters to enter the bloc tariff-free.
Because of it, said EU legislator Bernd Lange, “we have seen a drop in demand by 50% in Maine, which is obviously quite serious. So now we are making an offer to allow American lobster to come tariff-free into the EU."
For its part, the U.S. agreed to cut in half tariffs on EU imports worth about $160 million a year, including some prepared meals, crystal glassware and cigarette lighters. The tariff cuts will be retroactive to Aug. 1.
The deal approved on Thursday covers only a tiny portion of trans-Atlantic trade with the U.S., but the EU hopes it will have some symbolic value. And for the lobster industry, already hit hard by the coronavirus crisis, every piece of good news is welcome.
For the EU, which has had acrimonious relations with the Trump administration, a sign of goodwill will never hurt.
“We have more in common than divides us," said Lange. “This piece of legislation is an offer: it’s not about lobster for all. It’s about cooperation instead of confrontation.”
7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle
October 2, 2020, may not rank as one of those “where were you when” moments. But when news broke that the President of the United States and the First Lady tested positive for the novel coronavirus, there was certainly a sense that we were living through a historical moment (as if we already were not).
Over the following days, several biotech and pharmaceutical companies took the headlines. However, these weren’t the vaccine stocks that investors have committed to memory. These were companies that are leading the race for antiviral therapeutics.
And with a very high profile proof of concept, therapeutics may have had their moment. It’s far too early to say whether these drugs truly carry the answer. But from the outset of the pandemic, there has been a feeling that therapeutics may carry the ultimate solution to neutralizing the most severe effects of the novel coronavirus.
As you might expect, there is no shortage of companies in the therapeutic discussion. In this special presentation, we’re highlighting seven companies that you should be paying close attention to. If therapeutics nudge ahead of a vaccine, these stocks are likely to make strong upward moves.
View the "7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle".